Pertento Partners LLP Has $65.55 Million Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

Pertento Partners LLP raised its stake in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 26.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,975,374 shares of the company’s stock after buying an additional 626,373 shares during the period. Cellebrite DI accounts for approximately 5.6% of Pertento Partners LLP’s portfolio, making the stock its 3rd biggest holding. Pertento Partners LLP’s holdings in Cellebrite DI were worth $65,547,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in CLBT. Advisors Asset Management Inc. boosted its stake in Cellebrite DI by 130.5% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company’s stock valued at $52,000 after purchasing an additional 1,742 shares during the period. FMR LLC grew its position in Cellebrite DI by 136.3% in the 3rd quarter. FMR LLC now owns 5,616,757 shares of the company’s stock worth $94,586,000 after purchasing an additional 3,239,307 shares during the last quarter. Quantbot Technologies LP raised its position in shares of Cellebrite DI by 77.0% during the third quarter. Quantbot Technologies LP now owns 114,318 shares of the company’s stock valued at $1,925,000 after buying an additional 49,742 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Cellebrite DI during the third quarter worth about $478,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Cellebrite DI by 11.7% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 111,791 shares of the company’s stock valued at $1,883,000 after acquiring an additional 11,730 shares in the last quarter. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Stock Performance

Shares of CLBT opened at $19.46 on Friday. The stock has a fifty day moving average price of $20.85 and a two-hundred day moving average price of $19.87. The company has a market cap of $4.66 billion, a price-to-earnings ratio of -14.00, a PEG ratio of 4.27 and a beta of 1.52. Cellebrite DI Ltd. has a 52-week low of $10.25 and a 52-week high of $26.30.

Cellebrite DI (NASDAQ:CLBT) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. As a group, research analysts predict that Cellebrite DI Ltd. will post 0.3 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on CLBT shares. Lake Street Capital upped their target price on Cellebrite DI from $17.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, February 14th. Needham & Company LLC restated a “buy” rating and set a $28.00 price target on shares of Cellebrite DI in a research note on Thursday. Finally, JPMorgan Chase & Co. increased their target price on Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a report on Tuesday, February 11th. Seven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $23.43.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.